About HilleVax
HilleVax is a company based in Boston (United States) founded in 2021 by David Socks.. HilleVax has raised $135 million across 1 funding round from investors including Lightspeed Venture Partners, Franklin Templeton and RA Capital. The company has 14 employees as of December 31, 2024. HilleVax offers products and services including Norovirus Vaccine. HilleVax operates in a competitive market with competitors including Savara Pharma, VBI Vaccines, Icosavax, Precigen and Intercell, among others.
- Headquarter Boston, United States
- Employees 14 as on 31 Dec, 2024
- Founders David Socks
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hillevax, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-147.27 M-19.18as on Dec 31, 2024
-
EBITDA
$-103.76 M20.91as on Dec 31, 2024
-
Total Equity Funding
$135 M (USD)
in 1 rounds
-
Latest Funding Round
$135 M (USD), Series D
Sep 08, 2021
-
Investors
Lightspeed Venture Partners
& 12 more
-
Employee Count
14
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HilleVax
HilleVax is a publicly listed company on the NASDAQ with ticker symbol HLVX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HilleVax
HilleVax offers a comprehensive portfolio of products and services, including Norovirus Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccine to prevent norovirus infections and reduce gastroenteritis outbreaks worldwide.
Unlock access to complete
Unlock access to complete
Funding Insights of HilleVax
HilleVax has successfully raised a total of $135M through 1 strategic funding round. The most recent funding activity was a Series D round of $135 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $135.0M
-
First Round
First Round
(08 Sep 2021)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series D - HilleVax | Valuation | Frazier Healthcare Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HilleVax
HilleVax has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Lightspeed Venture Partners, Franklin Templeton and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HilleVax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HilleVax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hillevax Comparisons
Competitors of HilleVax
HilleVax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Savara Pharma, VBI Vaccines, Icosavax, Precigen and Intercell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
|
| domain | founded_year | HQ Location |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
|
| domain | founded_year | HQ Location |
Developer of computationally designed VLP vaccines for treating multiple infections
|
|
| domain | founded_year | HQ Location |
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases, including antigens and adjuvants, were developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hillevax
Frequently Asked Questions about HilleVax
When was HilleVax founded?
HilleVax was founded in 2021.
Where is HilleVax located?
HilleVax is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is HilleVax a funded company?
HilleVax is a funded company, having raised a total of $135M across 1 funding round to date. The company's 1st funding round was a Series D of $135M, raised on Sep 08, 2021.
How many employees does HilleVax have?
As of Dec 31, 2024, the latest employee count at HilleVax is 14.
What does HilleVax do?
HilleVax was founded in 2021 and is based in Boston, United States. Focus is placed on biotechnology, specifically the development of vaccines against norovirus. The lead product, HIL-214, is a bivalent virus-like particle vaccine targeting GI.1 and GII.4 strains. Active immunization is provided to prevent acute gastroenteritis caused by norovirus, with operations centered on clinical advancement in the vaccine sector.
Who are the top competitors of HilleVax?
HilleVax's top competitors include Savara Pharma, VBI Vaccines and Sinovac.
What products or services does HilleVax offer?
HilleVax offers Norovirus Vaccine.
Is HilleVax publicly traded?
Yes, HilleVax is publicly traded on NASDAQ under the ticker symbol HLVX.
Who are HilleVax's investors?
HilleVax has 13 investors. Key investors include Lightspeed Venture Partners, Franklin Templeton, RA Capital, Frazier Healthcare Partners, and Perceptive Advisors.
What is HilleVax's ticker symbol?
The ticker symbol of HilleVax is HLVX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.